Application

17131130 · RNA Modulating Oligonucleotides with Improved Characteristics for the Treatment of Duchenne and Becker Muscular Dystrophy

Filed 2020-12-22 · Abandoned The official file ↗ · Art unit 1635 · Examiner Richard A Schnizer Typical · CPC C12N 15/113 · BioMarin Technologies B.V. · BIOMARIN PHARMACEUTICAL INC.

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

35.6 mo

to disposition 45.6 mo

Statutes raised

103 112 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.